From discovery to deal: Creating, protecting and licensing intellectual property

European Legal update: 10.03.-24.03.2026.

Legal assistant Liis Pormeister compiled the material. Company law Commission presents proposal for a new single set of corporate rules Proposed: 18 March 2026 The European Commission has presented its proposal for EU Inc., a new single set of corporate rules. It will provide a single harmonised set of corporate rules that companies can choose instead of […]

Life sciences and healthcare newsletter on key regulatory developments across the Baltics

As cross-border innovation, investment and service provision continue to accelerate across the Baltic region, stakeholders are increasingly focused on how regulation shapes market entry and growth opportunities. From clinical trials and health data systems to digitalisation, access to medicines and advertising rules, regulatory expectations in the Baltic life sciences and healthcare sector are evolving rapidly. […]

EU Biotech Playbook: Core legal issues & regulatory hurdles

A major victory in high‑stakes pharmaceutical patent litigation

We represented an international pharmaceutical company during complex patent litigation before Harju County Court. This case was notable for its exceptional technical complexity and its strategic importance for market access in the pharmaceutical sector. The claimant, a global originator pharmaceutical group, alleged that our client’s generic medicinal product infringed a European patent. They sought extensive […]